Immunotherapy, a revolutionary approach in cancer treatment, harnesses the body's immune system to combat cancer cells. This innovative therapy has shown promising results in treating various types of cancer, offering a new ray of hope for patients worldwide.
Immunotherapy works by stimulating or restoring the immune system's ability to fight off cancer. It can be categorized into two broad types: active and passive. Active immunotherapy enhances the immune system's response to cancer, while passive immunotherapy involves the administration of immune system components, such as man-made immune system proteins.
Immunotherapy includes a variety of treatments, such as Monoclonal Antibodies, Cancer Vaccines, Non-specific Immunotherapies, and Checkpoint Inhibitors. Monoclonal Antibodies are lab-made versions of immune system proteins that can be designed to attack specific parts of cancer cells. Cancer Vaccines, on the other hand, trigger the immune system to fight cancer. Non-specific Immunotherapies generally boost the immune system in a general way, while Checkpoint Inhibitors help the immune system recognize and attack cancer cells.
Immunotherapy has significantly transformed modern healthcare, offering potential solutions to previously untreatable cancers. However, like all therapies, it comes with its set of challenges. The most notable is the unpredictability of the immune response, which can sometimes lead to severe side effects. Nonetheless, ongoing research and clinical trials are geared towards improving the efficacy and safety of immunotherapy.
Immunotherapy marks a significant milestone in the evolution of cancer treatments. As physicians, understanding the intricacies of this novel therapy is essential to delivering optimal patient care. Despite its challenges, the potential of immunotherapy to revolutionize cancer treatment is immense, making it a cornerstone in the future of oncology.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation